Management of Arrested Labor in a Primigravida at 38 Weeks Gestation
Intravenous oxytocin administration is the most appropriate next step in management for this patient with arrested labor despite adequate contraction strength. 1
Assessment of the Current Situation
- The patient is a 23-year-old primigravida at 38 weeks with spontaneous rupture of membranes and painful contractions
- Cervical examination shows 8 cm dilation, 90% effacement, with the head at 0 station
- Contraction strength is 200 Montevideo units every 10 minutes (adequate strength)
- After 4 hours, the cervix remains unchanged despite adequate contractions
- Fetal heart rate tracing is normal
Management Algorithm
Step 1: Confirm Diagnosis of Active Phase Arrest
- Active phase arrest is defined as no cervical change despite adequate uterine contractions 1
- The patient meets criteria with 4 hours of no cervical change despite 200 Montevideo units of contraction strength 1
Step 2: Evaluate for Potential Causes
- Assess for cephalopelvic disproportion (CPD), which occurs in 25-30% of active phase arrest cases 1, 2
- Consider other factors: fetal malposition, macrosomia, or insufficient uterine contractility 1
- In this case, estimated fetal weight is 3600g (8lb), which is not macrosomic
Step 3: Select Appropriate Intervention
- Oxytocin augmentation is the first-line treatment for active phase arrest when CPD is not evident 1, 3
- Research shows that extending oxytocin augmentation for at least 4 hours in active-phase arrest is safe and effective 4, 5
- Oxytocin should be titrated carefully to avoid uterine hyperstimulation 1, 3
Why Oxytocin is the Correct Choice
- The patient has adequate contractions (200 Montevideo units) but may benefit from enhanced uterine activity 1
- FDA guidelines support oxytocin use for stimulation of labor when progress is inadequate 3
- Studies show that 92% of women with active-phase arrest delivered vaginally after oxytocin augmentation 4
- Even with no progress after 2 hours of oxytocin, 74% of nulliparas still achieved vaginal delivery 4
Why Other Options Are Not Appropriate
- Amnioinfusion (Option A): Not indicated as there is no evidence of cord compression or thick meconium 6
- Cervical examination in 2 hours (Option B): Delaying intervention is not appropriate when active phase arrest is already established 1
- Cesarean delivery (Option C): Premature without first attempting oxytocin augmentation 1, 2
- Operative vaginal delivery (Option E): Contraindicated at 8cm dilation (not fully dilated) 1
Important Considerations
- Monitor fetal heart rate closely during oxytocin administration to detect any signs of distress 3
- If no progress occurs after 4 hours of adequate oxytocin augmentation, reassess for CPD 1, 2
- If evidence of CPD emerges (increasing molding, deflexion, or asynclitism without descent), consider cesarean delivery 1, 2
- The presence of normal fetal heart rate tracing supports continued labor management rather than immediate cesarean 1
Oxytocin Administration Protocol
- Start at a low dose (1-2 mU/min) and increase gradually in increments of 1-2 mU/min 3
- Titrate to achieve effective contractions while avoiding uterine hyperstimulation 3
- Discontinue immediately if signs of fetal distress or uterine hyperactivity occur 3
- Continue for at least 4 hours before considering cesarean for arrest if fetal status remains reassuring 4, 5